Aerobic or resistance training improves anthropometric and metabolic parameters in overweight/obese women without any significant alteration in plasma vaspin levels

Sport Sciences for Health

Volumn 9, Issue 3, 2013, Pages 121-126

  Safarzade, Alireza ^a   Abbaspour Seyedii, Arshin ^b   Talebi Garakani, Elahe ^a   Fathi, Rozita ^a   Saghebjoo, Marziyeh ^c  

^a UNIVERSITY OF MAZANDARAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF BIRJAND   (Iran)

Author keywords

Exercise training; Obesity; Serpin A12; Weight reduction

Indexed keywords

EID: 84887904217     PISSN: 18247490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11332-013-0157-6     Document Type: Article

References (32)

1. Cameron AJ, Zimmet PZ, Shaw JE, Alberti KG (2009) The metabolic syndrome: in need of a global mission statement. Diabet Med 26(3): 306-309.
2. Caballero B (2007) The global epidemic of obesity: an overview. Epidemiol Rev 29: 1-5.
3. Lee MK, Jekal Y, Im JA et al (2010) Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 411(5-6): 381-385.
4. James PT (2004) Obesity: the worldwide epidemic. Clin Dermatol 22(4): 276-280.
5. Magkos F, Yannakoulia M, Chan JL, Mantzoros CS (2009) Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu Rev Nutr 29: 223-256.
6. Wozniak SE, Gee LL, Wachtel MS, Frezza EE (2009) Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54: 1847-1856.
7. Blüher M (2012) Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41(2): 176-182.
8. Chang HM, Lee HJ, Park HS et al (2010) Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity 18(11): 2105-2110.
9. Hida K, Wada J, Eguchi J et al (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102: 10610-10615.
10. Klöting N, Kovacs P, Kern M et al (2011) Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54: 1819-1823.
11. Gulcelik NE, Karakaya J, Gedik A et al (2009) Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 160: 65-70.
12. Youn BS, Klöting N, Kratzsch J et al (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377.
13. von Loeffelholz C, Mohlig M, Arafat AM et al (2010) Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 162: 507-513.
14. El-Mesallamy HO, Kassem DH, El-Demerdash E, Amin AI (2011) Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 60(1): 63-70.
15. Chang HM, Park HS, Park CY et al (2010) Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism 59: 1276-1281.
16. Stepan H, Kralisch S, Klostermann K et al (2010) Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 59: 1054-1056.
17. Cakal E, Ustun Y, Engin-Ustun Y et al (2010) Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 27(7): 491-495.
18. Handisury A, Riedl M, Vila G et al (2010) Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg 20: 198-203.
19. Golpaie A, Tajik N, Masoudkabir F et al (2011) Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw 22(4): 181-186.
20. Karvonen MJ, Kentala E, Mustala O (1957) The effects of training on heart rates. A "longitudinal" study. Ann Med Exp Biol Fenn 35: 307-310.
21. Tan BK, Heutling D, Chen J et al (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57: 1501-1507.
22. Cho JK, Han TK, Kang HS (2010) Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 108: 347-353.
23. Oberbach A, Kirsch K, Lehmann S et al (2010) Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes Facts 3: 328-331.
24. Kadoglou NP, Fotiadis G, Kapelouzou A et al (2013) The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes. Diabet Med 30(2): 41-50.
25. Kim JY, Kim ES, Jeon JY, Jekal Y (2011) Improved insulin resistance, adiponectin and liver enzymes without change in plasma vaspin level after 12 weeks of exercise training among obese male adolescents. Korean J Obes 20: 138-146.
26. Kim SM, Cho GJ, Yannakoulia M et al (2011) Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations. Metabolism 60(9): 1294-1299.
27. Martos-Moreno GA, Kratzsch J, Körner A et al (2011) Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes 35(10): 1355-1362.
28. Seeger J, Ziegelmeier M, Bachmann A et al (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93: 247-251.
29. Akbarzadeh S, Nabipour I, Jafari SM et al (2012) Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 95(1): 132-138.
30. Cinar N, Gülçelik NE, Aydín K et al (2011) Serum vaspin levels in hypothyroid patients. Eur J Endocrinol 165: 563-569.
31. Li K, Li L, Yang M et al (2011) Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur J Endocrinol 164: 905-910.
32. Heiker JT, Klöting N, Kovacs P et al (2013) Vaspin inhibits kallikrein 7 by serpin mechanism. Cell Mol Life Sci 70(14): 2569-2583.